Collegium Pharmaceutical, Inc (COLL): Shareholders' Equity
$301.68M
As of 2025-12-31
$311.91M
As of 2026-06-30
+15.7%
3-year compound annual growth
+10.2%
5-year compound annual growth
+13.5%
10-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $301.68M | +31.8% | 2026-02-26, Balance as of period end |
| 2024-12-31 | $228.84M | +17.1% | 2026-02-26, Balance as of period end |
| 2023-12-31 | $195.43M | +0.3% | 2026-02-26, Balance as of period end |
| 2022-12-31 | $194.84M | -4.0% | 2025-02-27, Balance as of period end |
| 2021-12-31 | $202.93M | +9.1% | 2024-02-22, Balance as of period end |
| 2020-12-31 | $186.03M | +112.8% | 2023-02-23, Balance as of period end |
| 2019-12-31 | $87.43M | -4.5% | 2022-02-24, Balance as of period end |
| 2018-12-31 | $91.58M | -12.0% | 2020-02-27, Balance as of period end |
| 2017-12-31 | $104.08M | -22.9% | 2019-02-27, Balance as of period end |
| 2016-12-31 | $134.91M | +58.6% | 2018-03-07, Balance as of period end |
| 2015-12-31 | $85.07M | n/m | 2017-03-10, Balance as of period end |
| 2014-12-31 | -$89.35M | n/m | 2016-03-18, Balance as of period end |
| 2013-12-31 | -$68.22M | n/a | 2016-03-18, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Collegium Pharmaceutical, Inc (COLL) | 2025-12-31 | $301.68M | +31.8% |
| Corcept Therapeutics Inc (CORT) | 2025-12-31 | $647.80M | -4.7% |
| Emergent BioSolutions Inc. (EBS) | 2025-12-31 | $522.60M | +8.2% |
| Arrowhead Pharmaceuticals, Inc. (ARWR) | 2025-09-30 | $503.42M | +163.5% |
| Pacira BioSciences, Inc. (PCRX) | 2025-12-31 | $693.11M | -11.0% |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 2025-12-31 | $788.80M | +7.7% |
| Supernus Pharmaceuticals, Inc. (SUPN) | 2025-12-31 | $1.06B | +2.5% |
| Harmony Biosciences Holdings, Inc. (HRMY) | 2025-12-31 | $870.22M | +32.0% |
| ANI Pharmaceuticals Inc (ANIP) | 2025-12-31 | $540.72M | +33.9% |
Compare COLL, CORT, EBS, ARWR side by side · Screen every company in Pharmaceutical Preparations ↗